GRUSF · Grown Rogue International Inc. · Financials
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | FY2027 (G) | FY2026 (G) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|---|
| $55M – $63M | $38M – $41M | $32.43M | $26.62M | $3.64M | $17.76M | $9.38M | $4.24M | $3.92M | |
| — | — | $18.28M | $13.38M | — | — | — | — | — | |
| — | — | $14.15M | $13.24M | $2.37M | $8.12M | $6.1M | $1.85M | $852.6K | |
| — | — | 43.62% | 49.74% | 65.17% | 45.75% | 65.05% | 43.53% | 21.72% | |
| — | — | $702.26K | $993.38K | — | — | — | — | $64.91K | |
| — | — | $14.74M | $13.18M | — | — | — | — | — | |
| — | — | -$593.49K | $59.98K | $4.25M | $957.15K | $701.58K | -$1.57M | -$7.62M | |
| — | — | -1.83% | 0.23% | — | 5.39% | 7.48% | -37.14% | -194.22% | |
| — | — | $108.77K | $1.05M | — | — | — | — | -$7.56M | |
| — | — | $150.33K | $77.51K | — | — | — | — | — | |
| — | — | $149.15K | — | — | — | — | — | — | |
| — | — | $5.43M | -$12.17M | — | — | — | — | — | |
| — | — | $1.6M | $3.86M | $370.93K | $245.36K | $150.54K | — | — | |
| — | — | -$1.5M | -$27.03K | — | — | — | — | — | |
| — | — | $3.23M | -$16M | — | — | — | — | — | |
| USD/shares | — | — | $0.01 | -$0.08 | — | — | — | — | — |
| USD/shares | — | — | $0.01 | -$0.08 | — | — | — | — | — |
| shares | — | — | 243.45M | 209.44M | — | — | — | — | — |
| shares | — | — | 250.86M | 209.44M | — | — | — | — | — |
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 47 similar-size Drug Manufacturers - Specialty & Generic companies (of 99 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 |
|---|---|---|
| New Jersey | $11,335,672 | $334,559 |
| Oregon | $11,059,993 | $12,093,606 |
| Michigan | $10,032,271 | $12,936,028 |
| Corporate | — | $1,258,131 |
By Geography (USD)
| Component | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|
| United States | $4,239,604 | $3,924,983 | $1,932,128 | $156,066 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Product | $32,427,936 | $25,364,193 | — | — | — | — | — | — |
| Products | — | — | $22,424,169 | $17,757,283 | $9,034,618 | $3,846,223 | $3,924,983 | $1,932,128 |
| Services | — | — | $929,016 | — | $344,055 | $393,381 | — | — |
| Service | — | $1,258,131 | — | — | — | — | — | — |